Today's weight management market is shaped by consumers seeking sustainable metabolic health, improved body composition, and long-term wellbeing. As a result, weight management formulations have expanded well beyond calorie control to include microbiome health, metabolic efficiency, and muscle preservation.
This shift is accelerating across the natural products industry, where brands are actively seeking multi-targeted, clinically supported ingredient solutions that align with clean-label expectations and modern lifestyle trends. Manufacturers are also responding to growing demand for GLP-1–adjacent formulations designed to support lean muscle maintenance, digestive resilience, satiety, and metabolic balance.
To support innovation in this category, Maypro offers a portfolio of science-backed ingredients that target weight management through complementary mechanisms, including:
- Microbiome modulation*
- SIRT1 activation for mitochondrial and anti-glycation support*
- Pancreatic lipase inhibition to help reduce fat absorption*
- Upregulation of CPT protein expression to support fat metabolism*
- Intestinal barrier function support*
AKK Probio
A Microbiome Modulator for Metabolic Health
Akkermansia muciniphila is one of the most extensively researched advanced probiotics for metabolic health and gut barrier support. AKK Probio is available in both probiotic (live) and postbiotic (inactivated) forms, each with self-affirmed GRAS status. As one of the first A. muciniphila ingredient to achieve GRAS status in both formats, AKK Probio gives formulators flexible, science-driven options for developing advanced microbiome solutions targeting metabolic health applications.
Research indicates that AKK Probio is distinct from the Lactobacillus and Bifidobacterium species commonly used in today's probiotic market. Through its ability to metabolize mucin and generate short-chain fatty acids, along with its production of two key proteins that activate cells along the gut barrier, it supports healthy GLP-1 secretion, strengthens intestinal barrier integrity, and promotes metabolic balance via targeted microbiome modulation.
Clinical Research Results
An 8-week human clinical trial demonstrated the following results for both probiotic and postbiotic forms:
- Reduction in body fat*
- Reduction in body mass index (BMI)*
- Reduction in triglyceride levels*
- An increase in healthy microbial populations
Alluvia® Purple Tea Extract
Targeted Polyphenolic Modulation for Healthy Body Composition Support
As the clinical use and consumer adoption of GLP-1 receptor agonists continues to accelerate, there is growing attention on secondary physiological effects, particularly reductions in lean muscle mass, alterations in how the body allocates energy, and the need for long-term strategies that support favorable body composition outcomes during and after therapy. This has created a formulation demand for bioactive ingredients that extend beyond glycemic control to include metabolic resilience, oxidative stress mitigation, and muscle-preserving metabolic signaling.
Alluvia® is a patented, clinically characterized extract derived from Kenyan-grown purple tea (Camellia sinensis var.), differentiated by its unique phytochemical profile and standardized concentration of high-value polyphenols and anthocyanins. Unlike conventional green or black tea extracts, Alluvia® is specifically enriched in rare flavonoid structures, including its proprietary marker compound GHG® (gallocatechin gallate derivatives complex), alongside a spectrum of anthocyanin pigments not typically present in significant quantities in standard black or green tea preparations.
Mechanistically, these bioactives support a multi-pathway metabolic profile that includes redox modulation via ROS scavenging and Nrf2-related antioxidant signaling, improved metabolic partitioning through AMPK-linked regulation of lipid and glucose utilization, and balanced inflammatory signaling associated with chronic metabolic stress. Collectively, these effects contribute to improved metabolic efficiency and may help support lean tissue preservation during caloric deficit states.
Alluvia® represents an advanced tea-derived bioactive system designed not simply for antioxidant labeling, but for targeted metabolic positioning in formulations addressing weight management, GLP-1 co-supplementation strategies, and healthy aging body composition support.
Clinically Researched Results
Clinical research demonstrates that daily supplementation with 100 mg of Alluvia® may support
- Reduction in total and subcutaneous fat
- Reduction in body mass index (BMI)
- Improvement in body composition*
Sirtmax®
SIRT1 Activation for Metabolic and Longevity Support
Sirtmax® is a patented black turmeric (Kaempferia parviflora) extract clinically studied for its ability to activate SIRT1, often referred to as the "longevity gene." Through its dual-action mechanism, Sirtmax® supports mitochondrial activity while helping to inhibit glycation—two important pathways associated with metabolic health and healthy aging.
Clinical Research Results
Clinical studies have shown that 100mg of Sirtmax® daily contributes to
- Reduction in visceral fat and total body fat*
- Reduction in body mass index (BMI)*
- Reduction in waist circumference*
- Suppression of weight gain compared to placebo*
Request Product BriefB-3™
Probiotic for Metabolic Rebalance
B-3™ (Bifidobacterium breve B-3) is a Human-Residential Bifidobacteria (HRB) strain clinically studied for its role in supporting metabolic function and healthy body composition through microbiome modulation.
Research suggests B-3™ helps support a healthy gut microbiome by promoting a healthy balance between Firmicutes and Bacteroidetes, two major microbial groups linked to metabolic health, while also supporting intestinal barrier function and healthy inflammatory-marker balance.
Clinically Researched Results
A 12-week clinical study demonstrated that ingesting 5B CFUs of B-3™ daily reduced waist and hip circumference and significantly improved body composition from baseline through
- Reduction of body fat mass*
- Reduction of body mass index (BMI)*
- Lowering of total body weight*
Formulating for the Future of Weight Management
The future of weight management innovation lies in multi-mechanistic, clinically substantiated formulations that address metabolism, microbiome balance, body composition, and healthy aging simultaneously.
Whether you are developing capsules, powders, gummies, functional beverages, or GLP-1–adjacent support products, Maypro's portfolio of science-backed ingredients offers formulation flexibility and differentiated positioning for next-generation metabolic health solutions.
To learn more, request clinical research, technical documentation, or samples from the Maypro team, please reach out to us by clicking the button below.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
